These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9304076)

  • 1. [Pharmacological, toxicological, deontologic, and medico-legal aspects of the use of appetite suppressant agents in "weight-loss cures"].
    Carolei L; Ermio G; Accorinti N; Meo G; Lamberti V; De Sarro G
    Minerva Med; 1997; 88(7-8):317-26. PubMed ID: 9304076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appetite suppressants. A review.
    Silverstone T
    Drugs; 1992 Jun; 43(6):820-36. PubMed ID: 1379155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of tolerance to drugs that suppress food intake.
    Fernstrom JD; Choi S
    Pharmacol Ther; 2008 Jan; 117(1):105-22. PubMed ID: 17950459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological treatment of obesity. Drugs with predominantly anorectic action].
    Ortensio A; Avagnina S; Costantino A
    Minerva Dietol Gastroenterol; 1988; 34(2):109-16. PubMed ID: 3050610
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychotomimetic effects of anorectic drugs.
    Khan SA; Spiegel DA; Jobe PC
    Am Fam Physician; 1987 Aug; 36(2):107-12. PubMed ID: 3618447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appetite-suppressant drugs and valvular heart disease.
    Paoletti CF
    N Engl J Med; 1999 Feb; 340(6):477; author reply 478-80. PubMed ID: 9988621
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug Insight: appetite suppressants.
    Bray GA
    Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):89-95. PubMed ID: 16265126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-obesity drugs: use, mechanisms and clinical importance.
    Adam O; Forth W
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):232-8. PubMed ID: 11430630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychoactive drug use among overweight psychiatric patients: problem aspect of anorectic drugs.
    Angle HV; Carroll JA; Ellinwood EH
    Chem Depend; 1980; 4(1-2):47-55. PubMed ID: 6927577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amphetamine appetite suppressant saga.
    Prescrire Int; 2004 Feb; 13(69):26-9. PubMed ID: 15055225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of obesity. Past, present, and future.
    Wangsness M
    Minn Med; 2000 Nov; 83(11):21-6. PubMed ID: 11126476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug treatment of obesity].
    Héraïef E; Burckhardt P
    Ther Umsch; 1989 May; 46(5):309-18. PubMed ID: 2662470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychoactive drug use among overweight psychiatric patients: problems aspects of anorectic drugs.
    Angle HV; Carroll JA; Ellinwood EH
    Chem Depend; 1980; 4(1-2):47-55. PubMed ID: 7226287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological therapies for obesity.
    Kaplan LM
    Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug strategies for the treatment of obesity.
    Alemany M; Remesar X; Fernández-López JA
    IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appetite-suppressant drugs and valvular heart disease.
    Myers MD
    N Engl J Med; 1999 Feb; 340(6):476-7; author reply 478-80. PubMed ID: 9988619
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonpharmacologic and pharmacologic management of weight gain.
    Greenberg I; Chan S; Blackburn GL
    J Clin Psychiatry; 1999; 60 Suppl 21():31-6. PubMed ID: 10548140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appetite-suppressant drugs and valvular heart disease.
    Shapiro S
    N Engl J Med; 1999 Feb; 340(6):477-8; author reply 478-80. PubMed ID: 9988622
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of appetite suppressants among health sciences undergraduate students in Southern Brazil.
    Zubaran C; Lazzaretti R
    Einstein (Sao Paulo); 2013; 11(1):47-52. PubMed ID: 23579743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-obesity drugs--mechanism and medical indication of appetite suppressants].
    Nishida M
    Nihon Rinsho; 2001 Mar; 59(3):620-4. PubMed ID: 11268619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.